Will Beta

Main Menu

  • Volatility
  • Systematic Risk
  • Returns Of Assets
  • Beta Data
  • Finance Debt

Will Beta

Header Banner

Will Beta

  • Volatility
  • Systematic Risk
  • Returns Of Assets
  • Beta Data
  • Finance Debt
Systematic Risk
Home›Systematic Risk›PET imaging shows how COVID vaccines confuse cancer detection

PET imaging shows how COVID vaccines confuse cancer detection

By Rogers Jennifer
May 24, 2021
0
0



Researchers at the Mayo Clinic in Rochester, Minnesota compared PET scans of patients before and after receiving Pfizer-BioNTech or Moderna COVID-19 vaccinations and observed increased absorption of FDG and carbon- 11 (C-11) choline by axillary and ipsilateral lymph nodes. deltoids. There was no axillary lymph node uptake visible before the vaccinations.

“These changes in PET results after COVID-19 vaccination are significant confusing traps that could lead to unnecessary biopsies and treatments unless properly recognized by the interpreting physicians,” wrote the first author, Dr. Dane Schroeder, a diagnostic radiologist.

Numerous recent case reports and small studies have shown that COVID-19 vaccinations with Moderna and Pfizer products produce minor side effects, including reactive lymphadenopathy. To date, systematic analysis of changes on PET due to COVID-19 vaccination is limited. Managing FDG-hungry lymph nodes in vaccinated patients presents a clinical challenge, especially given the widespread application of PET imaging in oncology, according to the authors.

In this retrospective analysis, researchers sought to assess the frequency and characteristics of abnormal absorption of FDG and C-11 choline on PET imaging performed on cancer patients after COVID-19 vaccination.

The study included 67 patients who had PET / CT or PET / MRI scans with FDG or C-11 choline between December 14, 2020, the first day vaccines were available in the United States, and the 10 March 2021. PET was performed with a median of 13 days after vaccination in patients who received one dose and 10 days after vaccination in patients who received two doses.

Two nuclear medicine physicians independently reviewed the images. Maximum standardized lymph node and deltoid absorption values ​​(SUVmax) greater than the SUV of the blood poolmax were considered positive. All C-11 choline PET scans were performed on patients for evaluation of prostate cancer.

Researchers observed positive axillary lymph node absorption in 10.4% (7/67) of patients undergoing FDG-PET scans and 23.1% (3/13) of patients undergoing choline C PET scans. -11. Ipsilateral deltoid uptake was present in 14.5% (8/55) of patients with documented injection laterality, including in 42.9% (3/7) of patients with positive axillary lymph nodes.

(A) A 57-year-old woman with right arm melanoma who received the first dose of COVID-19 vaccine (Pfizer-BioNTech) in the left deltoid 15 days before FDG PET / CT. Absorption of FDG is observed in the left axillary lymph nodes (arrow, SUVmax = 9.3). (B) A 62-year-old man with metastatic carcinoma of the prostate who received the second dose of COVID-19 vaccine (Pfizer-BioNTech) in the right deltoid seven days before C-11 choline PET / CT . Image courtesy of American Journal of Radiology.

“We did not observe any PET positive axillary lymph nodes beyond 24 days after vaccination. Thus, waiting 3 to 4 weeks after vaccination before undergoing a PET scan for an initial oncology evaluation may also be reasonable, especially in patients with a higher risk of axillary lymph node disease, ”the authors wrote.

Additionally, to avoid pitfalls in interpreting PET imaging at the Mayo Clinic, researchers implemented a new process of verbally screening patients for their vaccination history prior to PET scans because this information did not is not always readily available in their records. The screening data is entered in the patient’s file and made available to the interpreter.

“Interpreting physicians should recognize the characteristics of abnormal PET absorption after COVID-19 vaccination to guide optimal management of follow-up and reduce unnecessary biopsies,” concluded Schroeder and colleagues.

Copyright © 2021 AuntMinnie.com



Related posts:

  1. ACMG clinical practice resource to help guide the clinical management of patients at increased risk for breast, pancreatic and ovarian cancer
  2. Manage water-related risks – on site and in the watershed
  3. HEARD AT HALFTIME: WHO’s Ryan explains Olympic virus risk; sprint star Richardson ready to protest? More on DK Metcalf, but not track & field
  4. IoT-based access control device vulnerabilities put users and providers at risk
Tagsunited states

Recent Posts

  • War and acreage surprises drive grain market volatility
  • Bajaj Finance Offers Anti-Inflation Interest Rates on Term Deposits – Details
  • Pension fund assets grow by N843 billion in H1 2022
  • ADATA releases LEGEND 960 PCIe Gen4 x4 M.2 2280 SSD for PC and Sony PlayStation 5
  • Consumer and Business Debt Consolidation Market 2022 Data Analysis by Key Vendors like | Discover Personal Loans (US), Lending Club (US), Payoff (US)

Archives

  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021

Categories

  • Beta Data
  • Finance Debt
  • Returns Of Assets
  • Systematic Risk
  • Volatility
  • Terms and Conditions
  • Privacy Policy